Dechra Pharmaceuticals PLC — Share Issue/Capital Change 2014

Sep 9, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1730R

Dechra Pharmaceuticals PLC

09 September 2014

9 September 2014

Dechra® Pharmaceuticals PLC

(Dechra or the Company) 

Additional Listing

An application has been made to the Financial Conduct Authority and the London Stock Exchange for a total of 213,305 ordinary shares of 1 pence each (the Shares) to be admitted to the Official List.

These Shares are being reserved under a block listing and will be issued pursuant to the following schemes:

Scheme:	Shares:
Long Term Incentive Plan	141,305
Approved Share Option Scheme	14,000
Unapproved Share Option Scheme	58,000

These Shares will rank pari passu with the Company's existing shares in issue. It is expected that admission will become effective on 10 September 2014.

For further information, please contact

Zoe Goulding, Company Secretary            

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and relates products business.  Its expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

LISLIFETAEIAIIS